287 related articles for article (PubMed ID: 27004002)
1. Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
Liu QY; He CD; Zhou Y; Huang D; Lin H; Wang Z; Wang D; Wang JQ; Liao LP
World J Gastroenterol; 2016 Mar; 22(11):3242-51. PubMed ID: 27004002
[TBL] [Abstract][Full Text] [Related]
2. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
3. Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography.
Iwazawa J; Ohue S; Mitani T; Abe H; Hashimoto N; Hamuro M; Nakamura K
AJR Am J Roentgenol; 2009 Apr; 192(4):1057-63. PubMed ID: 19304714
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
[TBL] [Abstract][Full Text] [Related]
5. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
6. The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma.
Du F; Jiang R; Gu M; He C; Guan J
Radiol Med; 2015 Aug; 120(8):690-4. PubMed ID: 25698303
[TBL] [Abstract][Full Text] [Related]
7. Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Choi SJ; Kim J; Seo J; Kim HS; Lee JM; Park H
Abdom Imaging; 2014 Jun; 39(3):518-25. PubMed ID: 24519566
[TBL] [Abstract][Full Text] [Related]
8. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.
Miyayama S; Yamashiro M; Hashimoto M; Hashimoto N; Ikuno M; Okumura K; Yoshida M; Matsui O
J Vasc Interv Radiol; 2013 Apr; 24(4):501-8. PubMed ID: 23452552
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization.
Kakeda S; Korogi Y; Ohnari N; Moriya J; Oda N; Nishino K; Miyamoto W
J Vasc Interv Radiol; 2007 Dec; 18(12):1508-16. PubMed ID: 18057285
[TBL] [Abstract][Full Text] [Related]
10. Role of C-arm CT for transcatheter arterial chemoembolization of hepatocellular carcinoma: diagnostic performance and predictive value for therapeutic response compared with gadoxetic acid-enhanced MRI.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
AJR Am J Roentgenol; 2013 Sep; 201(3):675-83. PubMed ID: 23971463
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
12. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
[TBL] [Abstract][Full Text] [Related]
13. Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.
Chung WS; Lee KH; Park MS; Lee YJ; Kwon J; Baek SE; Kim MJ
AJR Am J Roentgenol; 2012 Aug; 199(2):349-59. PubMed ID: 22826396
[TBL] [Abstract][Full Text] [Related]
14. C-arm CT for assessing initial failure of iodized oil accumulation in chemoembolization of hepatocellular carcinoma.
Iwazawa J; Ohue S; Kitayama T; Sassa S; Mitani T
AJR Am J Roentgenol; 2011 Aug; 197(2):W337-42. PubMed ID: 21785062
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of three-dimensional angiography with a flat panel detector of direct conversion type in a transcatheter arterial chemoembolization procedure for hepatocellular carcinoma: initial experience.
Kakeda S; Korogi Y; Hatakeyama Y; Ohnari N; Oda N; Nishino K; Miyamoto W
Cardiovasc Intervent Radiol; 2008; 31(2):281-8. PubMed ID: 18026792
[TBL] [Abstract][Full Text] [Related]
16. Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma.
Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
Invest Radiol; 2016 Feb; 51(2):121-6. PubMed ID: 26488373
[TBL] [Abstract][Full Text] [Related]
17. Safety margins of hepatocellular carcinoma demonstrated by 3-dimensional fused images of computed tomographic hepatic arteriography/unenhanced computed tomography: prognostic significance in patients who underwent transcatheter arterial chemoembolization.
Tajima T; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Kakihara D; Honda H
J Comput Assist Tomogr; 2010; 34(5):712-9. PubMed ID: 20861774
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Nakano MM; Yamamoto A; Nishida N; Hamuro M; Hamamoto S; Jogo A; Sohgawa E; Kageyama K; Minami T; Miki Y
Jpn J Radiol; 2019 Jul; 37(7):543-548. PubMed ID: 31055710
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
[TBL] [Abstract][Full Text] [Related]
20. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Kaufmann S; Schulze M; Spira D; Horger M
Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
